Patient Centric Health Innovation by CanBiotech

GTCbio's Diabetes summit will be showcasing a few patient entrepreneurs working on different aspects of treatment and management of the disease. The summit will be held at the Hyatt Regency on April 5th – 7th, 2017 in Boston, MA. The following entrepreneurs and their companies will be participating in the Patient Entrepreneur Panel:

• Karin Hehenberger, Founder and CEO of LyfeBulb
  LyfeBulb is dedicated to improve the quality of life of those living with chronic disease through investing in innovation, promoting Patient Entrepeneurs and growing an online community.

• Charles O’Connell, Founder and CEO of Fitscript
  Fitscript is dedicated to helping people living with diabetes reach their fitness goals by getting rid of the highs and lows, and by getting in the GLUCOSEZONE.

• Shantanu Gaur, Co-Founder and CSO of Allurion Technologies
  Allurion’s Elipse device is the first procedureless gastric balloon for weight loss. It is swallowed and naturally excreted without surgery, endoscopy, or anesthesia.

• Matthew Loper, CEO of Wellth
  Wellth helps payers and providers thrive in a value-based environment by paying patients to be healthy, with a goal of ensuring the adoption and success of value-based care.

• Robert Geho, Co-Founder and CEO of Diasome Pharmaceuticals Inc
  Diasome is developing breakthrough insulin efficacy solutions for people with Type 1 and Type 2 diabetes using hepatocyte targeted nanotechnology based drug delivery systems.
  
  Read more...